Human Molecular Genetics · 2022 · 17 citations · 47 references
MedicineOphthalmologyVision ScienceAgingOcular DiseaseOcular PathologyMacular DegenerationMacular DisordersRetinal DiseaseRetinal DisordersRetinal PathologyRetinal Pigment EpitheliumAge-related Retinal DegenerationComplement Activation PathwaysComplement System ActivationComplement System DysregulationRetinal AgingRetinal Disease MechanismsRetinal Pigment Epithelium DegenerationUnfolded Protein Response
EFEMP1 R345W is a dominant mutation causing Doyne honeycomb retinal dystrophy/malattia leventinese (DHRD/ML), a rare blinding disease with clinical pathology similar to age-related macular degeneration (AMD). Aged Efemp1 R345W/R345W knock-in mice (Efemp1ki/ki) develop microscopic deposits on the basal side of retinal pigment epithelial cells (RPE), an early feature in DHRD/ML and AMD. Here, we assessed the role of alternative complement pathway component factor B (FB) in the formation of these deposits. RNA-seq analysis of the posterior eyecups revealed increased unfolded protein response, decreased mitochondrial function in the neural retina (by 3 months of age) and increased inflammatory pathways in both neural retina and posterior eyecups (at 17 months of age) of Efemp1ki/ki mice compared with wild-type littermate controls. Proteomics analysis of eye lysates confirmed similar dysregulated pathways as detected by RNA-seq. Complement activation was increased in aged Efemp1ki/ki eyes with an approximately 2-fold elevation of complement breakdown products iC3b and Ba (P < 0.05). Deletion of the Cfb gene in female Efemp1ki/ki mice partially normalized the above dysregulated biological pathway changes and oral dosing of a small molecule FB inhibitor from 10 to 12 months of age reduced sub-RPE deposits by 65% (P = 0.029). In contrast, male Efemp1ki/ki mice had fewer sub-RPE deposits than age-matched females, no elevation of ocular complement activation and no effect of FB inhibition on sub-RPE deposits. The effects of FB deletion or inhibition on Efemp1ki/ki mice supports systemic inhibition of the alternative complement pathway as a potential treatment of dry AMD and DHRD/ML.
47
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon, Chet Birger, Helga Thorvaldsdóttir et al. · Cell Systems · 2015 · 14.5K citations · Full text
Salmon provides fast and bias-aware quantification of transcript expression
Rob Patro, Geet Duggal, Michael I. Love et al. · Nature Methods · 2017 · 13.7K citations · Full text
GENCODE reference annotation for the human and mouse genomes
Adam Frankish, Mark Diekhans, Anne-Maud Ferreira et al. · Nucleic Acids Research · 2018 · 3.5K citations · Full text